In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives
dc.contributor.author | Evdokimov N.M. | |
dc.contributor.author | Lamoral-Theys D. | |
dc.contributor.author | Mathieu V. | |
dc.contributor.author | Andolfi A. | |
dc.contributor.author | Frolova L.V. | |
dc.contributor.author | Pelly S.C. | |
dc.contributor.author | Van Otterlo W.A.L. | |
dc.contributor.author | Magedov I.V. | |
dc.contributor.author | Kiss R. | |
dc.contributor.author | Evidente A. | |
dc.contributor.author | Kornienko A. | |
dc.date.accessioned | 2012-01-18T08:06:28Z | |
dc.date.available | 2012-01-18T08:06:28Z | |
dc.date.issued | 2011 | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.identifier.citation | Bioorganic and Medicinal Chemistry | |
dc.identifier.citation | 19 | |
dc.identifier.citation | 23 | |
dc.identifier.citation | http://www.scopus.com/inward/record.url?eid=2-s2.0-80655146928&partnerID=40&md5=387132308634a89e1234ac70dffd5f10 | |
dc.identifier.issn | 9680896 | |
dc.identifier.other | 10.1016/j.bmc.2011.09.051 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/18999 | |
dc.subject | 1 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl benzoate | |
dc.subject | 1 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl pivalate | |
dc.subject | 1 hydroxy 4,5,7,12b tetrahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 2(3a1h) one | |
dc.subject | 1,2 dihydroxy 3a1,4,5,12b tetrahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(2h) one | |
dc.subject | 1,2,3 trihydroxy 2,3,5,12b tetrahydroxy1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(3a1h) one | |
dc.subject | 1,2,3,4 tetrahydroxy 3,3a,3a1,4,5,12b hexahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(2h) one | |
dc.subject | 2 (triisopropylsilyloxy) 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 ol | |
dc.subject | 2 (triisopropylsilyloxy)2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl acetate | |
dc.subject | 2 (triisopropylsilyloxy)2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl palmitate | |
dc.subject | 2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl acetate | |
dc.subject | 2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl benzoate | |
dc.subject | 2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl palmitate | |
dc.subject | 2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl stearate | |
dc.subject | 2 hydroxy 4h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(5h) one | |
dc.subject | 2,3a,4,5,7,12b hexahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate | |
dc.subject | 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl dibenzoate | |
dc.subject | 3,3a dihydroxy 7 oxo 2,3,3a,3a,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate | |
dc.subject | 3a hydroxy 7 oxo 2,3,3a,3a1,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,triyl triacetate | |
dc.subject | 7 oxo 2,3,3a1,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,triyl triacetate | |
dc.subject | 7 oxo 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate | |
dc.subject | 7 oxo 5,7 dihydro 4h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl acetate | |
dc.subject | 7 thioxo 2,3,3a,3a1,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,3a tetraol | |
dc.subject | 7 thioxo 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate | |
dc.subject | alkene | |
dc.subject | cytostatic agent | |
dc.subject | hydroxyl group | |
dc.subject | long chain fatty acid | |
dc.subject | lycorine | |
dc.subject | paclitaxel | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | antineoplastic activity | |
dc.subject | apoptosis | |
dc.subject | article | |
dc.subject | cancer inhibition | |
dc.subject | controlled study | |
dc.subject | derivatization | |
dc.subject | dihydroxylation | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | glioblastoma | |
dc.subject | human | |
dc.subject | in vitro study | |
dc.subject | lung non small cell cancer | |
dc.subject | melanoma | |
dc.subject | nonhuman | |
dc.subject | solid tumor | |
dc.subject | structure activity relation | |
dc.subject | tumor cell line | |
dc.subject | Amaryllidaceae | |
dc.title | In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives | |
dc.type | Article |